Filters: Author is Bermudez, Luiz E [Clear All Filters]
2007
Danelishvili L, Wu M, Stang BV, Harriff M, Cirillo SLG, Cirillo S, Cirillo JD, Cirillo J, Bildfell RJ, Arbogast B et al..
2007. Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection.. Proceedings of the National Academy of Sciences of the United States of America. 104(26):11038-43. Abstract
2006
Danelishvili L, Young LS, Bermudez LE.
2006. In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.. Microbial drug resistance (Larchmont, N.Y.). 12(1):1-6. Abstract
Yamazaki Y, Danelishvili L, Wu M, Hidaka E, Katsuyama T, Stang BV, Petrofsky M, Bildfell RJ, Bermudez LE.
2006. The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells.. Cellular microbiology. 8(5):806-14. Abstract
Yamazaki Y, Danelishvili L, Wu M, Macnab M, Bermudez LE.
2006. Mycobacterium avium genes associated with the ability to form a biofilm.. Applied and environmental microbiology. 72(1):819-25. Abstract
Tenant R, Bermudez LE.
2006. Mycobacterium avium genes upregulated upon infection of Acanthamoeba castellanii demonstrate a common response to the intracellular environment.. Current microbiology. 52(2):128-33. Abstract
Dam T, Danelishvili L, Wu M, Bermudez LE.
2006. The fadD2 gene is required for efficient Mycobacterium avium invasion of mucosal epithelial cells.. The Journal of infectious diseases. 193(8):1135-42. Abstract
2005
Danelishvili L, Wu M, Young LS, Bermudez LE.
2005. Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.. Antimicrobial agents and chemotherapy. 49(9):3707-14. Abstract
2004
Danelishvili L, Poort MJ, Bermudez LE.
2004. Identification of Mycobacterium avium genes up-regulated in cultured macrophages and in mice.. FEMS microbiology letters. 239(1):41-9. Abstract
Bermudez LE, Yamazaki Y.
2004. Effects of macrolides and ketolides on mycobacterial infections.. Current pharmaceutical design. 10(26):3221-8. Abstract







